8th International Symposium on Hodgkin Lymphoma
October 23, 2010 - October 26, 2010
| Gürzenich Cologne
All major aspects of biology, molecular pathology, staging, treatment and survivor ship are covered. There is a special emphasis on new biological aspects, innovative treatment approaches and survivorship. Innovative satellite symposia, scientific sessions and a number of workshops complement the program.
Presentations
Hodgkin`s Lymphoma in Adolescents: French Experience and Conclusions Workshop on HL in Adolescents: a Controversy?
October 23, 2010 14:00
Evidence for Radiotherapy in Advanced Stage Hodgkin Lymphoma, Volume and Dose Workshop on Defining RT Field and Dose
October 23, 2010 16:15
RT Dose in Early Stages – the GHSG Studies Workshop on Defining RT Field and Dose
October 23, 2010 16:20
RT or Not RT (for Pediatric Hodgkin Lymphoma): That is the Question! Workshop on Defining RT Field and Dose
October 23, 2010 16:25
Achievements and Challenges Workshop on Defining RT Field and Dose
October 23, 2010 16:30
Highly Conformal Radiotherapy for Hodgkin Lymphoma, IMRT, Arc Therapy, Proton Therapy Workshop on Defining RT Field and Dose
October 23, 2010 16:35
Imaging for Highly Conformal Radiotherapy for Hodgkin Lymphoma, PET-Study from Memorial Sloan Kettering Workshop on Defining RT Field and Dose
October 23, 2010 16:45
Uncertainties in Highly Conformal Radiotherapy for Hodgkin Lymphoma Workshop on Defining RT Field and Dose
October 23, 2010 17:00
Leukaemic Stem Cells: AML show the way The HL Stem Cell
October 24, 2010 09:00
Classical Hodgkin Lymphoma Microenvironment. Pathologic Aspects and the Role of CD40 / CD40L Lymphoma Microenvironment
October 24, 2010 10:00
Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma? Lymphoma Microenvironment
October 24, 2010 10:30
State of the Art and Future Perspectives Early Stages
October 25, 2010 10:15
Early FDG-PET Scan Confirms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients Early Stages
October 25, 2010 10:30
State of the Art for Hodgkin Lymphoma Treatment: The GHSG Perspective Lunch Symposium Roche Pharma AG: State-of-the-Art and Future Approaches
October 25, 2010 12:00
Optimizing Outcome in Newly Diagnosed CLL Lunch Symposium Roche Pharma AG: State-of-the-Art and Future Approaches
October 25, 2010 12:30
Hodgkin Lymphoma in Non-Western Countries Special Challenges
October 25, 2010 14:00
Hodgkin Lymphoma and HIV Infection (HDHIV): Prognostic Factors in 596 Patients (Pts) within the European Group for the Study of HIV and Tumours Special Challenges in HL
October 25, 2010 14:20
Autologous Stem Cell Transplantation for Adolescents and Young Adults with Relapsed or Refractory Hodgkin Lymphoma Special Challenges
October 25, 2010 14:30
Survivorship in Hodgkin Lymphoma: Lessons Learned from Pediatric Oncology Survivorship
October 25, 2010 16:00
Quality of Life in Hodgkin Lymphoma Patients with special emphasis on Fatigue Survivorship
October 25, 2010 16:15
A Prospective Study of Breast Magnetic Resonance Imaging and Mammographic Screening in Hodgkin Lymphoma Survivors Survivorship
October 25, 2010 17:00
Coronary Artery Disease in Patients Treated for Hodgkin Lymphoma: Preliminary Results Using Computed Angiography Tomography Survivorship
October 25, 2010 17:15
Mantle cell lymphoma – Recent Results & Ongoing Challenges Dinner Symposium Ortho Biotech Division of Janssen-Cilag GmbH: New Aspects of Lymphoma Therapy
October 25, 2010 18:00
Follicular Lymphoma – Bortezomib in the relapsed/refractory setting Dinner Symposium Ortho Biotech Division of Janssen-Cilag GmbH: New Aspects of Lymphoma Therapy
October 25, 2010 18:30
Relapse of Hodgkin’s Lymphoma After Autologous Stem Cell Transplantation (ASCT): Identification of Prognostic Factors Predicting Outcome Transplantation
October 26, 2010 09:40
Promising Results for Patients with Relapsed or Refractory Hodgkin Lymphoma Treated with the Oral mTOR Inhibitor Everolimus New Drugs
October 26, 2010 11:00
PET in the Staging of Hodgkin Lymphoma PET
October 26, 2010 14:00
PET During Follow-up PET
October 26, 2010 14:40
FDG-PET in the Design of Involved node Radiotherapy PET
October 26, 2010 15:10
PET assessment of residual tissue in advanced-stage HL: Final analysis of the HD15-PET trial Advanced Stages
October 26, 2010 17:00
Intensified ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin’s Lymphoma Advanced Stages
October 26, 2010 17:10
BEACOPP, ABVD and High Tumor Burden Advanced Stages
October 26, 2010 17:20
Infos
| Date | October 23, 2010 - October 26, 2010 |
|---|---|
| Program-Link: | http://hodgkinsymposium.org/program/ |
| Website: | http://www.hodgkinsymposium.org/ |
| Location: | Gürzenich Cologne; |
| Organizer: | German Hodgkin Study Group; |
| Category: | Medicine; |
Partner Societies
Content of the webcasts is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
GERMAN SOCIETY OF RADIO-ONCOLOGY
CROATIAN IMMUNOLOGICAL SOCIETY
SOCIEDAD ARGENTINA DE IMMUNOLOGIA
Latest Presentations
Please activate JavaScript and Flash to see this video.
Videos are not working? If the videos are not working on your computer, make sure you have installed the latest Flash Player and javascript is enabled in your browser.
Latest Congresses
March 15, 2012
November 17, 2011
September 07, 2011
August 31, 2011
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.